Lorcaserin was associated with significant weight loss among overweight and obese individuals without compromising cardiovascular safety, according to a large, randomized trial published Aug. 26 in The New England Journal of Medicine and presented at the European Society of Cardiology (ESC) Congress in Munich.

Most consumers at risk for heart disease either fail to look at the nutritional labels on their food or have trouble understanding them, according to a study presented this week at European Society of Cardiology (ESC) Congress 2018.

The FDA is mandating a new warning label on all sodium-glucose cotransporter-2 (SGLT2) inhibitors after the drugs were linked to 12 cases of Fournier’s gangrene in diabetic patients over the past five years.

Among 477,516 people in the Kaiser Permanente Southern California health system who were treated for high blood pressure, those who reached systolic blood pressure below 110 mm Hg at any point during a one-year period were twice as likely to faint or fall as patients who remained above that threshold.

The National Diabetes Education Program (NDEP) published an update to its “Guiding Principles” for managing the care of patients with diabetes or prediabetes.

Researchers are cautioning physicians to be wary when prescribing antibiotics to hypertensive patients after a study published in Physiological Genomics found individual genetic makeup can significantly affect how a person’s blood pressure reacts to common drugs like vancomycin and minocycline.

Simply cranking up the thermostat a few degrees may help people manage their blood pressure, suggests new research in the Journal of Hypertension.

Weight gain after quitting smoking is associated with an increased short-term risk of type 2 diabetes (T2D), according to new research published in the New England Journal of Medicine.